Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRL1 | P41146 | 4/20 | 0.41 |
| ▸ | LTA4H | P09960 | 2/20 | 0.40 |
| ▸ | CCR1 | P32246 | 4/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | TACR2 | P21452 | 1/20 | 0.38 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.38 |
| ▸ | HTR1A | P08908 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7962985 | 0.93 | LTA4H (0.39) | OPRL1LTA4HCCR1KDM4EKMT2A | |
| SCHEMBL7969555 | 0.92 | OPRL1 (0.45) | OPRL1LTA4HCCR1KDM4EKMT2A | |
| SCHEMBL7953290 | 0.92 | LTA4H (0.38) | OPRL1LTA4HCCR1KDM4EKMT2A | |
| SCHEMBL7953579 | 0.91 | CCR1 (0.41) | OPRL1LTA4HCCR1KMT2ATACR2 | |
| SCHEMBL7969481 | 0.91 | LTA4H (0.38) | OPRL1LTA4HCCR1KMT2ATACR2 | |
| SCHEMBL7966953 | 0.90 | OPRL1 (0.39) | OPRL1LTA4HCCR1KMT2ATACR2 | |
| SCHEMBL7969312 | 0.90 | LTA4H (0.45) | OPRL1LTA4HCCR1KDM4EKMT2A | |
| SCHEMBL7953348 | 0.90 | MEN1 (0.47) | OPRL1LTA4HCCR1KMT2AOPRM1 | |
| SCHEMBL7953456 | 0.90 | OPRL1 (0.39) | OPRL1LTA4HCCR1KDM4EKMT2A | |
| SCHEMBL7965175 | 0.90 | OPRL1 (0.47) | OPRL1CCR1OPRM1HTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030004207-A1 | USE OF COMPOUNDS WHICH ACTIVATE A 5-HT RECEPTOR TO TREAT URINARY INCONTINENCE | SYNAPTIC PHARMACEUTICALS CORPORATION | 2003-01-02 | — | — | US | disclosed |
| US-6242450-B1 | SUBSTITUTED PIPERIDINES | ELI LILLY AND COMPANY | 2001-06-05 | — | — | US | disclosed |
| WO-2000006166-A1 | 5-HT1F ANTAGONISTS | ELI LILLY AND COMPANY (US) | 2000-02-10 | — | — | WO | disclosed |
| EP-0976746-A1 | 5-HT1F antagonists | ELI LILLY AND COMPANY (US) | 2000-02-02 | — | — | EP | disclosed |
| EP-0976747-A2 | Use of 5HT-1F receptor antagonists for treating anxiety disorders | ELI LILLY AND COMPANY (US) | 2000-02-02 | — | — | EP | disclosed |